Protagenic Therapeutics, Inc.

NasdaqCM:PTIX Stock Report

Mkt Cap: US$9.7m

Protagenic Therapeutics Company Information

Protagenic Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Protagenic Therapeutics, Inc.
  • Ticker: PTIX
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$9.681m
  • Shares outstanding: 17.29m
  • Website:


  • Protagenic Therapeutics, Inc.
  • 149 Fifth Avenue
  • Suite 500
  • New York
  • New York
  • 10010
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PTIXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDFeb 2016
MBPCDB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2016

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/01/27 00:00
End of Day Share Price2023/01/26 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.